The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein ...

A systematic review suggested that drugs targeting amyloid beta appeared to have no clinically meaningful positive effects, ...

Critics say the meta-analysis provides an inaccurate picture of anti-amyloid medications. Two of them have FDA approval.

These drugs were hailed by proponents as breakthroughs in the fight to treat Alzheimer’s disease, but a new independent ...

Alzheimer's Society responds to the claim that amyloid-targeting drugs show no clinically meaningful positive effects.

For seniors living with dementia and Alzheimer’s disease, day-to-day life can be a struggle, and in the event of an emergency ...

Drugs once hailed as a breakthrough in the fight against Alzheimer's disease do not meaningfully help patients, a major ...

Top drugmakers have spent more than a decade investigating and advancing anti-amyloid Alzheimer's medicines in clinical ...

The secret might be hidden in our blood. Boston researchers in a new study have found that a blood test can predict Alzheimer’s disease progression years before symptoms or brain scan changes. The ...

Combined and cumulative physical and social environmental exposure may be more closely linked to brain aging than a clinical ...

A Stanford and Mount Sinai project won a top prize at a global competition for agentic AI in Alzheimer's research.

It’s “a move away from a one-size-fits-all framework for Alzheimer’s disease.” ...